“Media experiences describe it as being a loophole,” states Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s very intentional policy.” Brunner has expressed irritation about how some coverage on the increase of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medicines or research peptides with credentialed https://billp309hrz6.life3dblog.com/profile